Convex is recognized as a highly successful CRO, providing a comprehensive range of clinical research, development, and communication services.
Convex is fully equipped to meet the fast growing requirements of the industry on compressed timelines and execute operational and financial efficiency with promptness, precision, reliability and adherence to the high quality standards of the ICH GCP Guideline, Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 and FDA Regulations Relating to Good Clinical Practice and Clinical Trials.